TOMORROWS TRANSPORTATION NEWS TODAY!

Tag: practices

DHL Expands Medical and Pharmaceutical Logistics Capacity in Germany

  • DHL Global Forwarding opens expanded Leipzig Life Sciences & Healthcare Hub
  • Frankfurt, Hamburg and Leipzig GxP facilities successfully achieve CEIV IATArecertification
  • Specially trained staff and state-of-the-art equipment for storage and handling oftemperature-controlled pharmaceutical products and drugs

DHL Global Forwarding, Deutsche Post DHL Group’s air and ocean freight specialist, has expanded its Life Sciences & Healthcare (LSH) facility in Leipzig by approximately 2,500 square meters. The center is very close to Leipzig Airport and houses state- of-the-art equipment for storing and handling temperature-controlled pharmaceutical and medical products, such as vaccinations. After Frankfurt am Main, Leipzig is the second DHL Global Forwarding facility to be expanded in terms of capacity and equipment. DHL has successfully achieved IATA CEIV Pharma recertification for its GxP (good practice) facilities in Frankfurt am Main, Hamburg and Leipzig, making the company ideally prepared in Germany to meet the logistical requirements related to importing and exporting Covid-19 vaccinations.

The previous trans shipment and warehouse space of approximately 2,200 square meters in Leipzig was more than doubled when the expansion was completed in the last quarter of 2020. The second warehouse covers more than 2,500 square meters and is divided into two temperature zones. In the larger zone comprising approximately 1,700 square meters, the temperature can be regulated between 15 and 25°C. The smaller zone of around 850 square meters can be cooled down to 2-8°C. This allows pharmaceutical products to be stored at an appropriately cool temperature, to ensure their integrity. Dry ice handling for passively cooled transport containers and handling of actively cooled transport containers are also part of the standard repertoire. The immediate proximity to Leipzig Airport ensures fast import and export times. Of course, the facility also operates under the highest safety and security standards, with systems in place to immediately report temperature deviations and fire risks, as well as break-ins.

DHL and IATA are jointly committed to ensuring that the pharmaceutical industries regulatory requirements are met. A standardized approach in air freight increases productivity, accuracy, and reliability, while enabling transport in compliance with all applicable regulations. DHL began IATA CEIV Pharma certification of its facilities worldwide in 2016, raising the bar in pharmaceutical logistics. After independent third-party audits and training courses for employees on site, the DHL GxP facilities in Frankfurt, Hamburg and Leipzig have successfully renewed the quality label. DHL Global Forwarding thus enhances transportation and storage quality levels of pharmaceutical goods, and the DHL station exceeds its usual quality standards. At each location, IATA verifies compliance with its Temperature Control Regulations (TCR), the European Union’s GDP (Good Distribution Practices) guidelines, and further requirements of the World Health Organization (WHO) and other regulatory bodies.

As the leader in the life sciences and healthcare sector, DHL provides its employees, at all levels, and in all functional areas around the world, with vital tools to meet the requirements of both its customers and the supervisory authorities. For example, it provided a special training program to implement IATA regulation standards at scale in key GxP (good practice) facilities worldwide. The Certified Life Sciences Specialist (CLSS) program, offered as part of the Certified initiative, provides a comprehensive curriculum of mandatory training and specialized courses and materials to convey the knowledge needed in this highly specialized industry. As with all of DHL’s temperature-controlled locations, all employees in Frankfurt, Hamburg and Leipzig who are involved in handling life sciences and healthcare products have successfully completed the training and are certified Life Science Specialists. This ensures that sensitive shipments are handled with the utmost care and in compliance with the highest industry standards.

Airbus Sees Airlines Seeking to Defer or Cancel Orders

PARIS (Reuters) – Airbus <EADSY> said in a stock market filing on Monday that customers could seek to cancel or postpone delivery of airliners and helicopters as the coronavirus crisis continues to escalate.

It issued the warning in an annual reference document ahead of its upcoming Amsterdam shareholder meeting, for which it urged participants to vote by proxy rather than attend in person due to widespread measures to slow the spread of the disease.

Airbus Chief Executive Guillaume Faury said earlier that several airlines had asked to defer deliveries, but that most were continuing to pay their deposits.

“Weaker market and economic conditions in China and their knock-on effects in other markets could result in requests by customers to postpone delivery or cancel existing orders for aircraft (including helicopters),” the filing said, though Faury said earlier there were some signs of recovery in China.

Airbus also detailed steps to improve compliance practices after paying a 3.6-billion-euro fine last month to settle a four-year multinational bribery probe.

But it warned that possible further investigations in other jurisdictions could trigger claims against it by shareholders, impact its ability to raise finance or limit its eligibility for public contracts, as well as harm future commercial sales.

Malaysian authorities last week cleared AirAsia Group <5099.KL> after Britain’s Serious Fraud Office faulted a sponsorship deal between former Airbus parent EADS and a motor racing team owned by the airline’s co-founders.

But the SFO probe, supported by Airbus’s own lawyers, caused a severe rift between AirAsia and its sole supplier, adding to doubts over whether long-haul unit AirAsiaX will take delivery of A330neo jets on order, three people close to the matter said.

AirAsia officials could not be reached for comment. Airbus declined comment.

Loss-making AirAsiaX has said only that it wants to defer delivery of A330neo jets due to the coronavirus crisis.

Deliveries of the wide-body aircraft have also been hit by the impact of U.S. tariffs on Airbus aircraft under a long-running trade dispute, as well as concerns about overcapacity.

Airbus trimmed A330 output in January from about four a month in 2019, Reuters reported earlier this month.

In Monday’s filing, Airbus said it would maintain production of the A330neo at 3.5 aircraft a month.

(Reporting by Tim Hepher; Editing by Mark Potter, William Maclean)